X0407 4 2023-05-26 0001034842 RIGEL PHARMACEUTICALS INC RIGL 0001331860 LAPOINTE ANTHONY GREGG C/O RIGEL PHARMACEUTICALS, INC. 611 GATEWAY BLVD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 true false Common Stock 2023-05-26 4 A 0 25000 0 A 75000 D Stock Option (Right to Buy) 1.32 2023-05-26 4 A 0 30000 0 A 2033-05-26 Common Stock 30000 30000 D The shares of Common Stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall fully vest on the date prior to the Company's next Annual Meeting, subject to the Reporting Person's continuous service on the Company's Board of Directors. The shares vest monthly over one (1) year from the date of grant, subject to the Reporting Person's continuous service on the Company's Board of Directors. Exhibit List: Exhibit 24 - Power of Attorney /s/ Raymond Furey (Attorney-in-Fact) 2023-07-12